Published online March 1, 2006
PEDIATRICS Vol. 117 No. 3 March 2006, pp. 898-902 (doi:10.1542/peds.2005-1995)

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation Related Collections Musculoskeletal System Social Bookmarking                         What's this?

SPECIAL ARTICLE

Screening for Developmental Dysplasia of the Hip: Recommendation Statement

US Preventive Services Task Force

Abbreviations: USPSTF—US Preventive Services Task Force • DDH—developmental dysplasia of the hip • AVN—avascular necrosis of the hip • AAP—American Academy of Pediatrics

The first 300 words of the full text of this article appear below.

The US Preventive Services Task Force (USPSTF) concludes that evidence is insufficient to recommend routine screening for developmental dysplasia of the hip (DDH) in infants as a means to prevent adverse outcomes (I recommendation).^*

The pathophysiology and natural history of DDH are poorly understood. There is evidence that screening leads to earlier identification; however, 60% to 80% of the hips of newborns identified as abnormal or as suspicious for DDH by physical examination and >90% of those identified by ultrasound in the newborn period resolve spontaneously and require no intervention. There is poor evidence (poor-quality studies) of the effectiveness of both surgical and nonsurgical interventions; avascular necrosis of the hip (AVN) is reported in 0% to 60% of children who are treated for DDH. Thus, the USPSTF was unable to assess the balance of benefits and harms of screening for DDH but was concerned about the potential harms associated with treatment of infants identified by routine screening.

	CLINICAL CONSIDERATIONS

 

• This USPSTF screening recommendation applies only to infants who do not have obvious hip dislocations or other abnormalities evident without screening. DDH represents a spectrum of anatomic abnormalities in which the femoral head and the acetabulum are aligned improperly or grow abnormally. DDH can lead to premature degenerative joint disease, impaired walking, and pain. Risk factors for DDH include female gender, family history of DDH, breech positioning, and in utero postural deformities. However, the majority of cases of DDH have no identifiable risk factors.
  
• Screening tests for DDH have limited accuracy. The most common methods of screening are serial physical examinations of the hip and lower extremities using the Barlow and Ortolani procedures and ultrasonography. The Barlow examination is performed by adducting a flexed hip with gentle posterior force to identify a dislocatable hip. The Ortolani examination is performed by abducting a flexed . . . [Full Text of this Article]

Address correspondence to Ned Calonge, MD, MPH, US Preventive Services Task Force, c/o Program Director, USPSTF, Agency for Healthcare Research and Quality, 540 Gaither Rd, Rockville, MD 20850. E-mail: uspstf@ahrq.gov

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. T. Mahan, J. N. Katz, and Y.-J. Kim To Screen or Not to Screen? A Decision Analysis of the Utility of Screening for Developmental Dysplasia of the Hip J. Bone Joint Surg. Am., July 1, 2009; 91(7): 1705 - 1719. [Abstract] [Full Text] [PDF]

				V. A. Moyer and D. Nelson Pediatricians and the US Preventive Services Task Force: A Natural Partnership to Enhance the Health of Children Pediatrics, July 1, 2008; 122(1): 174 - 176. [Full Text] [PDF]

				D. J. Sucato and Y.-J. Kim What's New in Pediatric Orthopaedics J. Bone Joint Surg. Am., June 1, 2008; 90(6): 1401 - 1411. [Full Text] [PDF]

				W. Hennrikus, R. Schwend, and J. Sarwark Early detection of DDH can lead to simple, effective treatment AAP News, September 1, 2007; 28(9): 10 - 10. [Full Text] [PDF]

				R. M. Schwend A Reappraisal of the Ortolani Examination for Developmental Hip Dysplasia AAP Grand Rounds, May 1, 2007; 17(5): 57 - 58. [Full Text] [PDF]

				N. Calonge and D. Petitti Screening for Developmental Dysplasia of the Hip: In Reply Pediatrics, March 1, 2007; 119(3): 653 - 654. [Full Text] [PDF]

				P. L. Schoenecker and J. M. Flynn Screening for Developmental Dysplasia of the Hip Pediatrics, March 1, 2007; 119(3): 652a - 653. [Full Text] [PDF]

				Screening for Developmental Dysplasia of the Hip Journal Watch (General), March 21, 2006; 2006(321): 4 - 4. [Full Text]